Cargando…

A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19

We evaluated the role of CRP and other laboratory parameters in predicting the worsening of clinical conditions during hospitalization, ICU admission, and fatal outcome among patients with COVID-19. Consecutive adult inpatients with SARS-CoV-2 infection and respiratory symptoms treated in three diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scotto, Riccardo, Lanzardo, Amedeo, Buonomo, Antonio Riccardo, Pinchera, Biagio, Cattaneo, Letizia, Sardanelli, Alessia, Mercinelli, Simona, Viceconte, Giulio, Perrella, Alessandro, Esposito, Vincenzo, Codella, Alessio Vinicio, Maggi, Paolo, Zappulo, Emanuela, Villari, Riccardo, Foggia, Maria, Gentile, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781962/ https://www.ncbi.nlm.nih.gov/pubmed/36560453 http://dx.doi.org/10.3390/vaccines10122043

Ejemplares similares

Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience
por: Gentile, Ivan, et al.
Publicado: (2021)

Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience
por: Moriello, Nicola Schiano, et al.
Publicado: (2023)

Diabetes and COVID-19: The potential role of mTOR
por: Pinchera, B., et al.
Publicado: (2022)

Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study
por: Scotto, Riccardo, et al.
Publicado: (2023)

Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection
por: Pinchera, Biagio, et al.
Publicado: (2023)

Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves
por: Cattaneo, Letizia, et al.
Publicado: (2023)

COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy)
por: Gentile, Ivan, et al.
Publicado: (2022)

Update on the Management of Surgical Site Infections
por: Pinchera, Biagio, et al.
Publicado: (2022)

Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
por: Viceconte, Giulio, et al.
Publicado: (2023)

Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma
por: Capoluongo, Ettore, et al.
Publicado: (2021)

Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?
por: Nardelli, Carmela, et al.
Publicado: (2021)

Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study
por: Gentile, Ivan, et al.
Publicado: (2022)

Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge
por: Scotto, Riccardo, et al.
Publicado: (2022)

SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience
por: Pinchera, Biagio, et al.
Publicado: (2022)

Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
por: Scotto, Riccardo, et al.
Publicado: (2021)

mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study
por: Pinchera, Biagio, et al.
Publicado: (2022)

Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2021)

Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2019)

Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series
por: Moccia, Marcello, et al.
Publicado: (2022)

Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19
por: Pinchera, Biagio, et al.
Publicado: (2023)

Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface Antigens
por: Zappulo, Emanuela, et al.
Publicado: (2019)

Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort)
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2020)

The role of curcumin in liver diseases
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2018)

Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients
por: Biagio, Pinchera, et al.
Publicado: (2022)

Current evidence on the management of hepatitis B in pregnancy
por: Maraolo, Alberto Enrico, et al.
Publicado: (2018)

Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection
por: Gentile, Ivan, et al.
Publicado: (2014)

Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis
por: Maraolo, Alberto Enrico, et al.
Publicado: (2022)

Chest CT in COVID-19 patients: Structured vs conventional reporting
por: Stanzione, Arnaldo, et al.
Publicado: (2021)

Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2022)

Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2022)

Cytometric analysis of patients with COVID-19: what is changed in the second wave?
por: Scalia, Giulia, et al.
Publicado: (2021)

Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection
por: Scalia, Giulia, et al.
Publicado: (2022)

Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
por: Cacciapuoti, Sara, et al.
Publicado: (2020)

COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak
por: Buonomo, Antonio, et al.
Publicado: (2020)

Clinicopathological and Dermoscopic Baselines in Patients with Lynch Syndrome
por: Paolino, Giovanni, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg
por: Capasso, Nicola, et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: The hidden part of the iceberg
por: Capasso, Nicola, et al.
Publicado: (2021)

Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers
por: Paolino, Giovanni, et al.
Publicado: (2022)

Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases
por: Tonziello, Gilda, et al.
Publicado: (2019)

Home Parenteral Nutrition in Patients with Intestinal Failure: Possible Undetected Complications
por: Santarpia, Lidia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h3vrvbr7k9cfqu616mslcjpb6k